UNiDAYS Launch Annual “Student Women of the Year 2022” Competition with $10,000 Prize Fund

3 years ago

The competition will reward entrepreneurs who are breaking boundaries SYDNEY, AUSTRALIA - News Direct - 8 March 2022 - To…

NCS fortifies market presence in Australia and APAC with S$325 million acquisition of The Dialog Group

3 years ago

Acquisition accelerates NCS' regionalisation strategy in APAC and increases synergies between Australia and Singapore Combines tech capabilities of NCS and…

Oasis Announces �Women�s Director Training Scholarship� Initiative for International Women�s Day in Cooperation with BDTI of Japan

3 years ago

Investment firm Oasis to sponsor board director training courses through The Board Director Training Institute of Japan for all qualified…

Fiserv Hires Miriam Park as General Manager for Korea

3 years ago

Fiserv strengthens its payment services business in Asia Pacific with appointment of cards veteran Miriam Park as General Manager for…

Cloud Comrade Is Now an SAP Gold Partner

3 years ago

SINGAPORE - Media OutReach - 8 March 2022 - Cloud Comrade announced today that it has achieved SAP gold Partner…

New Avetta One� Platform Provides Pegasus Customers with a Unified View of Supply Chain Risk for Companies & Suppliers

3 years ago

Global reach of Pegasus continues to expand with Avetta One, offering a single-source solution for managing health & safety, ESG…

Pano AI�s Early Bushfire Detection Technology Gives Southern Cross Forests More Tools to Prevent Bushfires in New South Wales

3 years ago

TUMUT, AUSTRALIA - News Direct - 8 March 2022 - Pano AI , the leader in early bushfire detection and…

Investigation Report on China’s Omalizumab Markets, 2016-2020 & 2021-2025: Developed by Novartis Europharm – The Only Approved antibody designed to Target and Block Immunoglobulin E (IgE) – ResearchAndMarkets.com

3 years ago

DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Omalizumab Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Omalizumab, developed by Novartis…

China Abiraterone Markets Investigation Report, 2016-2020 & 2021-2025: A CYP17 Inhibitor, Which is Mainly Clinically Used to Treat Prostate Cancer Patients – ResearchAndMarkets.com

3 years ago

DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Abiraterone Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Abiraterone is a CYP17…

China Express Delivery Industry Report 2021: Analysis 2016-2020, Competition Status 2016-2020, Cost & Prices 2016-2020, & Forecasts 2021-2025 – ResearchAndMarkets.com

3 years ago

DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Express Delivery Industry 2021-2025" report has been added to ResearchAndMarkets.com's offering. In 2020, China's…